investorscraft@gmail.com

Intrinsic Value of Concert Pharmaceuticals, Inc. (CNCE)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %312.3NaN
Revenue, $33NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m110NaN
Operating income, $m-78NaN
EBITDA, $m-76NaN
Interest expense (income), $mNaN
Earnings before tax, $m-80NaN
Tax expense, $m0NaN
Net income, $m-80NaN

BALANCE SHEET

Cash and short-term investments, $m143NaN
Total assets, $m165NaN
Adjusted assets (=assets-cash), $m22NaN
Average production assets, $m27601NaN
Working capital, $m134NaN
Total debt, $m15NaN
Total liabilities, $m53NaN
Total equity, $m112NaN
Debt-to-equity ratio0.134NaN
Adjusted equity ratio-1.338NaN

CASH FLOW

Net income, $m-80NaN
Depreciation, amort., depletion, $m2NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-55NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-0NaN
Free cash flow, $m-55NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m134
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount